Xspire Pharma is a privately held, specialty pharmaceutical company founded in late 2011 focusing on key primary care markets. Xspire’s key strategies include development of niche pharmaceuticals, aquisitions of approved NDA/ANDA drug, licensing of key brand names, and OTC Monograph formulations.